Pharmacy Podcast Network

In this episode of @darshantalks, we discuss Patient Centricity with guest Emma Sutcliffe. Emma Sutcliffe, Senior Vice President, Patient Insights and Solutions at Prime Global (https://primeglobalpeople.com/), talks about her experience hosting a webinar with two prominent industry leaders in the field of patient engagement.

Novartis is the gold standard in patient engagement and was used as a case study in that session. Patient engagement is not yet mainstream, so experts are trying to push it towards the companies. Business benefits highly from patient engagement because of the "triple wing" concept: get medical services, products for patients in time and patient-focused drug development.

Companies are 19% more likely to launch a drug with successful pharma if they've included patients within their clinical design program. It results in better medicines through the pipelines and patient activation. When patients become active, their patient activation measure (PAM) in patient-centred care is likely to rise on all four levels.

They will be 28% more likely to consume fewer healthcare services, which means that the burden on ER departments will reduce as people are more health literate; they can manage health crises independently. Her company has started to help those patients who have reduced activation because of stress levels during a traumatic event, pandemic or work anxiety. Pharma companies that are adding to their PAM improve society's health activation as a whole. She compares UK and US healthcare and speaks about their merits.

For the former, through the NHS, patients can try and circumvent diagnostic pathways to get treatments faster via patient activation. For the latter, it is that professional relationships between pharma companies and patient engagement groups are robust. Patients sometimes skirt around the rules and regulations to get access to medicines, but with patient engagement, they don't have to do that. She concludes with her observations on the present regional compliance challenges at play regarding pioneering global patient activation. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode, Dr. Gillian Bell, a Doctor of Clinical Pharmacy, shares her path from pharmacy school to her non-traditional PharmD job as Pharmacogenomics Lead, Genome Medical. 

On This Episode We Discuss: 

• Gillian’s education (Brief) 

• Dr. Bell's work experience prior to PGx (Brief) Residency 

• Gillian’s PGx work experience prior to Genome Medical (Brief) Mission Hospital 

• Brief description of Genome Medical, its mission, its services, its clients 

• Gillian’s roles and responsibilities as the Pharmacogenomics Lead at Genome Medical 

• What does a typical day at Genome Medical look like for its pharmacists? How do the pharmacists interact with the genetic counselors? 

• “Genetic Counseling” or “PGx Inclusive Medication Therapy Management’ do the pharmacists provide one or the other or both? Neither? To whom are the services provided? Providers and/or to patients? 

• Gillian’s advice to pharmacists who want to pursue a career in PGx 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Madelaine A. Feldman, MD, FACR

Dr. Madelaine Feldman is a rheumatologist in private practice with The Rheumatology Group in New Orleans, LA. She is President of the Coalition of State Rheumatology Organizations, Chair of the Alliance for Safe Biologic Medicines and past member of the American College of Rheumatology insurance subcommittee.

Dr. Feldman is a Clinical Assistant Professor of Medicine at Tulane University School of Medicine, and lectures extensively to patients, physicians, regulators, and legislators both locally and nationally, speaking before the Health subcommittee of Energy and Commerce in 2019.  She has spoken and written on the drug supply channel, particularly the effect that formulary construction and utilization management tools have on pricing and access to drugs (availability & affordability).

Dr. Feldman is honored to be the recipient of the American College of Rheumatology's 2021 Innovation in Clinical Care award. She received the Distinguished Service Award for Tulane Medical School, was named one of the Top Women in New Orleans by City Business in 2017 and is the former radio talk show host of “Driving with Dr. Mattie.”

Learn more about your ad choices. Visit megaphone.fm/adchoices

Enhancing Patient Care: Value of Pharmaceutical Medical Information Services

Taking into consideration the breadth of information available to healthcare professionals, what makes the information provided by manufacturers valuable?

Join us in this episode where Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers, The State University of New Jersey and guest speakers Patrick Reilly, PA, CEO phactMI and Dominick Albano, PharmD, Vice President Global Medical Information Pfizer discuss the value and clinical impact of medical information provided by manufacturers.

This is the final episode in a series of three podcasts. If you have not listened to our first two episodes, check them out with the links below:

●           phactMI: Collaborate, Elevate, Enhance Patient Care:

https://traffic.megaphone.fm/CSN3217426537.mp3?updated=1640013129 

●           Where Pharmacists Go for Medical Information: 

https://traffic.megaphone.fm/CSN9590480303.mp3?updated=1639087070 

 

Learn more about phactMI at www.phactMI.org/about/

Follow phactMI on LinkedIn, Facebook, and Twitter

References:

Albano D, Follman S, Patel YD, et al. Enhancing Patient Care: Value of Pharmaceutical Medical Information Services. J Nurse Pract. 2021;17:840-45.

phactMI. Enhanced Search. www.phactMI.org. Accessed November 10, 2021.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy CrossRoads host Bruce Kneeland will be covering the IPC Annual Conference 2022 .

IPC is excited to announce the return of the in-person IPC Conference! This esteemed event will be held April 12-15, 2022 at the fabulous Hotel del Coronado in San Diego, California! Register today to join us for 3 full days in sunny California where you will find opportunities to give back to community and pharmacy while learning about the latest industry trends and networking with other independents from across the nation. Help IPC support the local community by participating in our new outreach program, earn up to 9 hours of continuing education credit, network with 60+ industry leading vendors, and impart your pharmacy wisdom on the next generation of pharmacy students! Don’t miss this opportunity to participate in the event of the year!

Learn more about your ad choices. Visit megaphone.fm/adchoices

Ransomware is a major threat to any and all computer networks. All companies large, small, healthcare, nonhealthcare can be impacted by it. Ransomware is a cyber-attack where the user cannot obtain access to their system. They are criminal acts that much be treated as one, swift action must be taken to protect your system and your patients PHI. 

Join Jeff Hedges from the Pharmacy Compliance Guide and Becky Templeton from R.J. Hedges & Associates, as they discuss Ransomware, how to determine a HIPAA breach, what to do if you are a victim of Ransomware, how to report cyber-attacks, how to report a breach due to ransomware attack, how cyber insurance may help, what kind of fines may be associated with a cyber-attack, and the real steps to prepare for an OCR inspection.

Learn more about how to protect your pharmacy from Ransomware threats:

https://www.rjhedges.com/blog/topic/podcasts

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the Darshan Talks Podcast, host Darshan Kulkarni Pharm.D, MS, Esq. discuss 340B Pharmacy Programs with guest Rita Baskett. Rita Baskett RPh, MBA/MHA, CEO of Integrated Pharmacy Services, Inc. that is a consulting firm that concentrates on 340B solutions. The company focus on the integration of compliant pharmacy solutions to improve costs and health outcomes through the use of government programs (when applicable and qualified) and technology partners. 340B is a part of statute written in 1992 with the federal registrar that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. The hospital started using 340B for retail prescriptions and later it morphed into mix used areas including emergency room, observation status, etc. There are certain hospitals that qualify and one of the criteria is it has to be non-profit, the drugs are intended for outpatient use. The second criterion requires that the hospital have a sufficient Medicare disproportionate share hospital (DSH) adjustment percentage. DSH hospitals must have an adjustment percentage greater than 11.75 percent for the most recent cost reporting period ending before the calendar quarter involved. Sole community hospitals and Rural referral centers must have an adjustment percentage of greater than 8 percent.

Connect with Rita Baskett:

On LinkedIn: https://www.linkedin.com/in/rita-bask...

Email : [email protected]

Website: ipsconsults.com

Connect with us:

Website: http://www.darshantalks.com

Law Firm: http://www.kulkarnilawfirm.com

Twitter: https://twitter.com/darshantalks

LinkedIn: https://www.linkedin.com/in/darshanku...

----

Disclaimers:

1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact.

2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization.

3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product.

4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice.

5. This does not create an attorney-client relationship

#pharma #340B #darshantalks #hospital #federal

Learn more about your ad choices. Visit megaphone.fm/adchoices

Learn how Surescripts solutions are helping to revolutionize the specialty medications experience

Surescripts blog posts on pharmacy and specialty medications

The Rise of Pharmacy to the Front Lines of Care and Innovation

Avoiding Specialty Pharmacy Detours featuring findings from a Surescripts study in partnership with Accredo

An Exercise In Trust: One Multiple Sclerosis Patient’s Journey

Relevant UN-Scripted Podcast Episodes

The Future is Now for Specialty Medications

A Day in the Life of a Specialty Pharmacist

Press Releases

Surescripts Further Streamlines Specialty Prescribing Process With New Services For Specialty Pharmacies

Specialty Pharmacists Report Process Delays of Up To 10 Days To Get Patients Started On Treatment

 

Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of the PAIN POD, Mark Pain Guy Garofoli chats with Dr. Laura Meyer-Junco, PharmD, BCPS, CPE, an international expert on Over-the-Counter (OTC) self-care pain management, about the complexities of pain medications that are readily available for anyone and everyone in our society in dollar stores, gas stations, grocery stores, hotel gift shops, and pharmacies alike. Just how much info can be crammed into one analgesic pharmacy aisle? Tons! Laura provides some pearls and pointers to help us all help others with OTC pain medications. Join the discussion right here, right now, on the Pain Pod. Come one, come all, to the Pain Pod!!!

Resources

Pediatric OTC Pain Medication Dosing

https://medlineplus.gov/ency/patientinstructions/000783.htm

Dr. Laura Meyer-Junco Bio

https://www.painweek.org/media/read/laura-meyer-junco

Pain News Network (Pain Guy’s Recent PAINWeek Poster Video Interview)

https://www.painnewsnetwork.org/

Learn more about your ad choices. Visit megaphone.fm/adchoices

Overcoming Stigma in the Treatment of Substance Abuse Disorder

Stigma is often based on myth, superstition, or prejudice against another group. These beliefs, not based on fact or evidence, often lead to a negative impact on mental health – and is especially seen in patients with substance use disorder.

During COVID, the opioid epidemic has continued to rage through America, making it imperative that pharmacists and other health care providers go the extra mile to be conscious of how stigma hinders the treatment of those suffering from substance abuse disorder.

Guest: Dr. Thomas Franko, associate professor of pharmacy practice at Wilkes University in Wilkes-Barre, PA, and coordinator of the Pain, Palliative Care and Addiction APhA Special Interest Group. 

Learn more about your ad choices. Visit megaphone.fm/adchoices